WCLC 2025 - Posters & ePosters-P3.18.16 CROWD: Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab for Initially Unresectable Stage III NSCLC

P3.18.16 CROWD: Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab for Initially Unresectable Stage III NSCLC

Asset Subtitle

Ilias Houda

Meta Tag

Speaker Ilias Houda

Topic Clinical Trials in Progress